News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
710,646 Results
Type
Article (42082)
Company Profile (294)
Press Release (668270)
Section
Business (210254)
Career Advice (2086)
Deals (36610)
Drug Delivery (100)
Drug Development (82922)
Employer Resources (172)
FDA (16519)
Job Trends (15372)
News (355663)
Policy (33851)
Tag
Academia (2575)
Alliances (51293)
Alzheimer's disease (1318)
Approvals (16483)
Artificial intelligence (197)
Bankruptcy (364)
Best Places to Work (11757)
Biotechnology (188)
Breast cancer (219)
Cancer (1632)
Cardiovascular disease (130)
Career advice (1745)
CAR-T (113)
Cell therapy (328)
Clinical research (66620)
Collaboration (630)
Compensation (337)
COVID-19 (2628)
C-suite (145)
Data (1529)
Diabetes (200)
Diagnostics (6323)
Earnings (86837)
Employer resources (149)
Events (113440)
Executive appointments (542)
FDA (17358)
Funding (566)
Gene therapy (236)
GLP-1 (672)
Government (4472)
Healthcare (18926)
Infectious disease (2731)
Inflammatory bowel disease (118)
Interviews (320)
IPO (16704)
Job creations (4053)
Job search strategy (1489)
Layoffs (452)
Legal (8345)
Lung cancer (240)
Manufacturing (233)
Medical device (13332)
Medtech (13337)
Mergers & acquisitions (20215)
Metabolic disorders (538)
Neuroscience (1719)
NextGen: Class of 2025 (6633)
Non-profit (4522)
Northern California (1951)
Obesity (306)
Opinion (215)
Patents (142)
People (58703)
Phase I (20655)
Phase II (29316)
Phase III (21966)
Pipeline (651)
Postmarket research (2653)
Preclinical (8747)
Radiopharmaceuticals (245)
Rare diseases (318)
Real estate (6245)
Regulatory (22693)
Research institute (2360)
Resumes & cover letters (358)
Southern California (1688)
Startups (3718)
United States (17604)
Vaccines (615)
Weight loss (217)
Date
Today (147)
Last 7 days (622)
Last 30 days (2862)
Last 365 days (35281)
2025 (2977)
2024 (35769)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54794)
2019 (47400)
2018 (35771)
2017 (33137)
2016 (32663)
2015 (38615)
2014 (32516)
2013 (27631)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (777)
Arizona (213)
Asia (40317)
Australia (6456)
California (4478)
Canada (1628)
China (380)
Colorado (205)
Connecticut (212)
Europe (85886)
Florida (648)
Georgia (156)
Illinois (449)
Indiana (257)
Maryland (712)
Massachusetts (3484)
Michigan (192)
Minnesota (327)
New Jersey (1276)
New York (1285)
North Carolina (823)
Northern California (1951)
Ohio (164)
Pennsylvania (1045)
South America (1159)
Southern California (1688)
Texas (657)
Utah (132)
Washington State (447)
710,646 Results for "parnell pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Jabil Acquires Pharmaceutics International, Inc. (Pii)
February 4, 2025
·
4 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
February 3, 2025
·
7 min read
Press Releases
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
January 23, 2025
·
5 min read
Parnell Pharmaceuticals Holdings Ltd Announces Extension of Rights Offering
Parnell Pharmaceuticals Holdings Ltd announced the extension of the backstopped rights offering to raise gross proceeds of approximately US$4.0 million.
January 6, 2023
·
3 min read
Deals
Parnell Pharmaceuticals Holdings Ltd Announces Proposed Rights Offering
Parnell Pharmaceuticals Holdings Ltd (OTC Pink ® Open Market: PARNF) (“Parnell”) announced its intention to raise US$4.0 million through a backstopped rights offering at no charge (the “Rights Offering”) for qualifying shareholders of record as of December 6, 2022 (the “Record Date”).
December 1, 2022
·
3 min read
Parnell Pharmaceuticals Holdings Ltd Announces Commencement of Rights Offering
Parnell Pharmaceuticals Holdings Ltd commenced its previously announced backstopped rights offering to raise gross proceeds of approximately US$4.0 million.
December 6, 2022
·
4 min read
Press Releases
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
December 30, 2024
·
11 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Term Sheet for $27 Million in Funding for HOPE Clinic Acquisitions and Pharmaceutical Operations
January 7, 2025
·
8 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Execute Agreement for $27 Million Funding Transaction for HOPE Clinic Acquisition
January 28, 2025
·
8 min read
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentation at ASCO GI 2025
January 9, 2025
·
2 min read
1 of 71,065
Next
